Concepedia

Charles Frost

CF

Statistics

Publications

37

Citations

4K

H-Index

26

Active since

1979

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Pfizer (United States)

Bristol-Myers Squibb (Sweden)

University of Sheffield

Charles Frost is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, pharmacokinetics, and clinical pharmacology.

Publications per year

1979–2023

37

Publications

37

Apixaban Metabolism and Pharmacokinetics after Oral Administration to Humans

Nirmala Raghavan, Charles Frost, Zhigang Yu et al. · Drug Metabolism and Disposition · 2008 · 604 citations

, , +10

Apixaban, an oral, direct factor <scp>X</scp>a inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects

Charles Frost, Jessie J. Wang, Sunil Nepal et al. · British Journal of Clinical Pharmacology · 2012 · 363 citations · Full text

, , +13

Clinical laboratory measurement of direct factor Xa inhibitors: Anti-Xa assay is preferable to prothrombin time assay

Zhaoqing Wang, Charles Frost, Andrew Shenker et al. · Thrombosis and Haemostasis · 2010 · 353 citations

, , +17

Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end‐stage renal disease on hemodialysis

Xiaoli Wang, Giridhar Tirucherai, Thomas Marbury et al. · The Journal of Clinical Pharmacology · 2015 · 284 citations · Full text

, , +17

Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor<scp>X</scp>a inhibitor, in healthy subjects

Charles Frost, Sunil Nepal, Jessie Wang et al. · British Journal of Clinical Pharmacology · 2013 · 282 citations · Full text

, , +17

1–5 of 37